Alterations in penicillin binding protein gene of Streptococcus pneumoniae and their correlation with susceptibility patterns

International Journal of Antimicrobial Agents

Volumn 22, Issue 2, 2003, Pages 140-146

  Ohsaki, Yoshinobu ^a   Tachibana, Mineji ^a   Nakanishi, Kyoko ^a   Nakao, Shoko ^a   Saito, Kumiko ^a   Toyoshima, Eri ^a   Sato, Maki ^a   Takahashi, Toru ^a   Osanai, Shinobu ^a   Itoh, Yoshihisa ^a   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Drug resistance; Penicillin binding protein; Penicillin resistance; Streptococcus pneumoniae; Susceptibility

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFOZOPRAN; CLARITHROMYCIN; LEVOFLOXACIN; OLIGONUCLEOTIDE; PANIPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN G; SULBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CLASSIFICATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; INFECTION SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN BINDING PROTEIN GENE 1A; PENICILLIN BINDING PROTEIN GENE 2B; PENICILLIN BINDING PROTEIN GENE 2X; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

EID: 0043091887     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00118-3     Document Type: Article

References (26)

1. Ishida T., Hashimoto T., Arita M., Ito I., Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest. 114:1998;1588-1593.
2. Bartlett J.G., Mundy L.M. Community-acquired pneumonia. New Engl. J. Med. 333:1995;1618-1624.
3. Hansman D., Bullen M.M. A resistant pneumococcus. Lancet. 2:1967;264-265.
4. Doern G.V., Heilmann K.P., Huynh H.K., Rhomberg P.R., Coffman S.L., Brueggemann A.B. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:2001;1721-1729.
5. Doern G.V., Brueggemann A.B., Holley H.P., Rauch A.M. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995. Antimicrob. Agents Chemother. 40:1996;1208-1213.
6. Thornsberry C., Jones M.E., Hickey M.L., Mauriz Y., Kahn J., Sahm D.F. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated in the United States 1997-1998. J. Antimicrob. Chemother. 44:1999;749-759.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eleventh informational supplement. Wayne, PA: National Committee for Clinical Standards, 2001.
8. Kell C.M., Sharma U.K., Dowson C.G., Town C., Balganesh T.S., Spratt B.G. Deletion analysis of the essentiality of penicillin-binding proteins 1A, 2B, 2X of Streptococcus pneumoniae. FEMS. Microbiol. Lett. 106:1993;171-175.
9. Martin C., Sibold C., Hakenbeck R. Relatedness of penicillin-binding protein 1a genes from different clones of penicillin-resistant Streptococcus pneumoniae isolated in South Africa and Spain. EMBO. J. 11:1992;3831-3836.
10. Munoz R., Dowson C.G., Daniels M., et al. Genetics of resistant to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 6:1992;2461-2465.
11. Ubukata K., Muraki T., Igarashi A., Asahi Y., Konno M. Identification of penicillin and other β-lactam resistance in Streptococcus pneumoniae by polymerase chain reaction. J. Infect. Chemother. 3:1997;190-197.
12. Asahi Y., Ubukata K. Association of a Thr-371 substitution in a conserved amino acid motif of penicillin-binding protein 1A with penicillin resistance of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:1998;2267-2273.
13. Asahi Y., Takeuchi Y., Ubukata K. Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates. Antimicrob. Agents Chemother. 43:1999;1252-1255.
14. Ubukata K., Asahi Y., Yamane A., Konno M. Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J. Clin. Micobiol. 34:1996;592-596.
15. Nagai K., Shibasaki Y., Hasegawa K., et al. Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and β-lactam resistance, and to detect common macrolide resistance determinants. J. Antimicrob. Chemother. 48:2001;915-918.
16. Lynch J.P. III, Martinez F.J. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin. Infect. Dis. 34:2002;S27-S46.
17. Jorgensen J.H., Swenson J.M., Tenover F.C., et al. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae. J. Clin. Micobiol. 34:1996;2679-2684.
18. National Committee for Clinical Laboratory Standards. Perfomance standards for antimicrobial susceptibility testing-Eighth informational supplement. Approved Standard. Villanova, PA: National Committee for Clinical Laboratory Standards; 1998. M100-S8.
19. Visalli M.A., Jacobs M.R., Appelbaum P.C. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. Antimicrob. Agents Chemother. 41:1997;1867-1870.
20. Fasola E.L., Bajaksouzian S., Appelbaum P.C., Jacobs M.R. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob. Agents Chemother. 41:1997;129-134.
21. Ednie L.M., Visalli M.A., Jacobs M.R., Appelbaum P.C. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob. Agents Chemother. 40:1996;1950-1952.
22. Klugman K.P., Capper T., Widdowson C.A., Koornhof H.J., Moser W. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyrogens and Streptococcus pneumoniae: characterization of South African isolates. J. Antimicrob. Chemother. 42:1998;729-734.
23. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Standard M7-A3. Villanova, PA, USA: National Committee for Clinical Laboratory Standards; 1995.
24. Bartlett J.G., Breiman R.F., Mandell L.A., File T.M. Jr. Community-acquired pneumonia in adults: Guideline for management. Clin. Infect. Dis. 26:1998;811-838.
25. Davidson R., Cavalcanti R., Brunton J.L., et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:2002;747-749.
26. Sahm D.F., Peterson D.E., Critchley I.A., Thornsberry C. Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States. Antimicrob. Agents Chemother. 44:2000;2521-2524.